MEI Pharma Announces $75 Million Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
MEI Pharma (MEIP) PT Lowered to $4.50 at Oppenheimer
May 15, 2018 7:26 AM EDTOppenheimer lowered its price target on MEI Pharma (NASDAQ: MEIP) to $4.50 (from $6.50) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "We have expected that ME-401 will advance from phase Ib to a phase III study or a registration... More
